Abstract：
UNASSIGNED: In recent years, teledermatology has rapidly emerged as a healthcare delivery method with potential implications for managing chronic inflammatory dermatoses like atopic dermatitis (AD).
UNASSIGNED: This study assesses the utility of telemedicine in the management of AD by comparing virtual care with traditional in-office visits with the aim of identifying differences in clinical outcomes between these 2 healthcare delivery modalities.
UNASSIGNED: Patients of all ages with AD were recruited from 2 dermatology practices. Consecutive patients presenting to the clinics who met the inclusion criteria were invited to enrol in the study. Those who consented to participate were randomly assigned to the virtual or in-person arm of the study, with the opportunity to decline care in either study arm. The inclusion criteria required participants to have a confirmed diagnosis of AD. Exclusion criteria included significant comorbidity that might affect the course of treatment, inaccessibility to teleconsults such as not having a camera for video conferences, and self-declared limitations in operating Zoom. Patients were assessed at baseline (week 0), 4 to 6 weeks, and 8 to 12 weeks using 6 efficacy parameters.
UNASSIGNED: In the virtual group, all 6 dermatological measures suggested improved outcomes. Average Body Surface Area scores decreased (β = -.07, 95% CI = -0.1, -0.3) over the course of follow-up. Virtual care patients had 80% lower odds of moderate-to-severe uncontrolled disease (OR = 0.2; 95% CI = 0.06, 0.5) and pruritus (OR = 0.2, 95% CI = 0.05, 0.7) over time.
UNASSIGNED: This study supports teledermatology as a feasible and effective option for providing follow-up care for atopic dermatitis patients of various demographic standings.
UNASSIGNED: This study assesses the utility of telemedicine in the management of AD by comparing virtual care with traditional in-office visits with the aim of identifying differences in clinical outcomes between these 2 healthcare delivery modalities.
UNASSIGNED: Patients of all ages with AD were recruited from 2 dermatology practices. Consecutive patients presenting to the clinics who met the inclusion criteria were invited to enrol in the study. Those who consented to participate were randomly assigned to the virtual or in-person arm of the study, with the opportunity to decline care in either study arm. The inclusion criteria required participants to have a confirmed diagnosis of AD. Exclusion criteria included significant comorbidity that might affect the course of treatment, inaccessibility to teleconsults such as not having a camera for video conferences, and self-declared limitations in operating Zoom. Patients were assessed at baseline (week 0), 4 to 6 weeks, and 8 to 12 weeks using 6 efficacy parameters.
UNASSIGNED: In the virtual group, all 6 dermatological measures suggested improved outcomes. Average Body Surface Area scores decreased (β = -.07, 95% CI = -0.1, -0.3) over the course of follow-up. Virtual care patients had 80% lower odds of moderate-to-severe uncontrolled disease (OR = 0.2; 95% CI = 0.06, 0.5) and pruritus (OR = 0.2, 95% CI = 0.05, 0.7) over time.
UNASSIGNED: This study supports teledermatology as a feasible and effective option for providing follow-up care for atopic dermatitis patients of various demographic standings.
摘要：
■近年来，远程皮肤病学已迅速成为一种医疗保健服务方式，对治疗特应性皮炎（AD）等慢性炎症性皮肤病具有潜在影响。
■本研究通过比较虚拟护理与传统的办公室访问，评估了远程医疗在AD管理中的效用，目的是确定这两种医疗服务方式之间的临床结果差异。
■从2个皮肤病学实践中招募所有年龄的AD患者。连续向符合纳入标准的诊所就诊的患者被邀请参加研究。那些同意参与的人被随机分配到虚拟或面对面的研究中，有机会拒绝任何一个研究机构的护理。纳入标准要求参与者确诊为AD。排除标准包括可能影响治疗过程的重大合并症，无法访问电话会议，例如没有摄像机用于视频会议，以及操作缩放时自我声明的限制。患者在基线（第0周）进行评估，4到6周,和8至12周使用6个疗效参数。
■在虚拟组中，所有6项皮肤病学检查均提示结局改善.在随访过程中，平均体表面积评分下降（β=-0.07，95％CI=-0.1，-0.3）。随着时间的推移，虚拟护理患者发生中度至重度未控制疾病（OR=0.2；95％CI=0.06，0.5）和瘙痒（OR=0.2，95％CI=0.05，0.7）的几率降低了80％。
■这项研究支持远程皮肤病学作为一种可行和有效的选择，为各种人口统计学的特应性皮炎患者提供随访护理。
■本研究通过比较虚拟护理与传统的办公室访问，评估了远程医疗在AD管理中的效用，目的是确定这两种医疗服务方式之间的临床结果差异。
■从2个皮肤病学实践中招募所有年龄的AD患者。连续向符合纳入标准的诊所就诊的患者被邀请参加研究。那些同意参与的人被随机分配到虚拟或面对面的研究中，有机会拒绝任何一个研究机构的护理。纳入标准要求参与者确诊为AD。排除标准包括可能影响治疗过程的重大合并症，无法访问电话会议，例如没有摄像机用于视频会议，以及操作缩放时自我声明的限制。患者在基线（第0周）进行评估，4到6周,和8至12周使用6个疗效参数。
■在虚拟组中，所有6项皮肤病学检查均提示结局改善.在随访过程中，平均体表面积评分下降（β=-0.07，95％CI=-0.1，-0.3）。随着时间的推移，虚拟护理患者发生中度至重度未控制疾病（OR=0.2；95％CI=0.06，0.5）和瘙痒（OR=0.2，95％CI=0.05，0.7）的几率降低了80％。
■这项研究支持远程皮肤病学作为一种可行和有效的选择，为各种人口统计学的特应性皮炎患者提供随访护理。
